Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. (TECX): 5 pipeline candidates · ~39 mo cash runway · 2 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
38.8 months
D/E 0.07 · 0% dilution
Lead: Phase 2
5 candidates
N/A
2 buys · 7 sells (180d)
A transparent, data-derived signal for Tectonic Therapeutic, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$556.8M
Cash
$237.4M
Quarterly Burn
$18.4M
Runway
38.8 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (5 candidates)
| Drug | Phase |
|---|---|
| tx000045 | Phase 2 |
| tx000045- dose a | Phase 2 |
| tx000045- dose b | Phase 2 |
| tx2100 | Preclinical |
| tx45 | Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
108
Total value held
$321.2M
| Holder | Shares | Value |
|---|---|---|
| fmr llc | 2,816,494 | $87.1M |
| vanguard capital management llc | 947,064 | $29.3M |
| blackrock, inc. | 860,352 | $26.6M |
| braidwell lp | 847,151 | $26.2M |
| baker bros. advisors lp | 607,788 | $18.8M |
| susquehanna international group, llp | 293,475 | $9.1M |
| kennedy capital management llc | 286,682 | $8.9M |
| geode capital management, llc | 268,273 | $8.3M |
| marshall wace, llp | 229,595 | $7.1M |
| orbimed advisors llc | 226,600 | $7.0M |
Showing top 10 of 108 institutional holders of Tectonic Therapeutic, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Tectonic Therapeutic, Inc.'s pipeline?
Tectonic Therapeutic, Inc. (TECX) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Tectonic Therapeutic, Inc.'s lead drug candidate?
Tectonic Therapeutic, Inc.'s most advanced tracked candidate is tx000045 (Phase 2) for Hypertension, Pulmonary.
What is Tectonic Therapeutic, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Tectonic Therapeutic, Inc. has approximately 38.8 months of cash runway.
What is Tectonic Therapeutic, Inc.'s market capitalization?
Tectonic Therapeutic, Inc.'s market capitalization is approximately $556.8M.
Who is the CEO of Tectonic Therapeutic, Inc.?
Dr. Alise S. Reicin M.D., Ph.D. is the chief executive officer of Tectonic Therapeutic, Inc. (TECX).
Get the full picture on Tectonic Therapeutic, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.